{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:49:35Z","timestamp":1788918575603,"version":"build-2803163510"},"reference-count":104,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive Aspergillosis (IA) is one of the most common invasive fungal diseases and is accompanied by high morbidity and mortality. In order to maximize patient outcomes and survival, early and rapid diagnosis has been shown to be pivotal. Hence, diagnostic tools aiding and improving the diagnostic process are ambitiously searched for. In this context, polymerase chain reaction (PCR) may represent a potential candidate. Its additional value and benefits in diagnosis have been demonstrated and are scientifically established. Nevertheless, standardized and widespread usage is sparse because several factors influence diagnostic quality and need to be considered in order to optimize diagnostic performance and outcome. In the following review, the current role of PCR in the diagnosis of IA is explored, with special focus on the strengths and limitations of PCR in different settings.<\/jats:p>","DOI":"10.3390\/jof6010018","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T11:41:57Z","timestamp":1580125317000},"page":"18","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Blood Aspergillus PCR: The Good, the Bad, and the Ugly"],"prefix":"10.3390","volume":"6","author":[{"given":"Matthias","family":"Egger","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Jenks","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Diego, San Diego, CA 92093, USA"},{"name":"Clinical and Translational Fungal Research Group, University of California San Diego, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-2824","authenticated-orcid":false,"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria"},{"name":"Department of Medicine, University of California San Diego, San Diego, CA 92093, USA"},{"name":"Clinical and Translational Fungal Research Group, University of California San Diego, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-9311","authenticated-orcid":false,"given":"Juergen","family":"Prattes","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"ref_1","first-page":"528","article-title":"Galactomannan testing and aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis","volume":"55","author":"Eigl","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/myc.12927","article-title":"Invasive aspergillosis in critically ill patients: An autopsy study","volume":"62","author":"Tejerina","year":"2019","journal-title":"Mycoses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijantimicag.2015.05.017","article-title":"Influence of mould-active antifungal treatment on the performance of the aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test","volume":"46","author":"Eigl","year":"2015","journal-title":"Int. J. Antimicrob. Ag."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Wickes, B.L., Ilkit, M., Pincus, D.H., Daneshnia, F., Pan, W., Fang, W., and Boekhout, T. (2019). Identification of mycoses in developing countries. J. Fungi, 5.","DOI":"10.3390\/jof5040090"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14787210.2018.1558054","article-title":"Improving the rates of aspergillus detection: An update on current diagnostic strategies","volume":"17","author":"Jenks","year":"2019","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/myc.12881","article-title":"Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: Aspergillus galactomannan lateral flow assay versus aspergillus-specific lateral flow device test in bronchoalveolar lavage","volume":"62","author":"Jenks","year":"2019","journal-title":"Mycoses"},{"key":"ref_7","first-page":"249","article-title":"Bronchoalveolar lavage aspergillus galactomannan lateral flow assay versus aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies","volume":"78","author":"Jenks","year":"2019","journal-title":"J. Infect. Prev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12704","article-title":"Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis","volume":"61","author":"Hoenigl","year":"2018","journal-title":"Mycoses"},{"key":"ref_9","first-page":"150","article-title":"Triacetylfusarinine c: A urine biomarker for diagnosis of invasive aspergillosis","volume":"78","author":"Hoenigl","year":"2019","journal-title":"J. Infect. Prev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/myc.12679","article-title":"Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis","volume":"60","author":"Heldt","year":"2017","journal-title":"Mycoses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/ciy181","article-title":"Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009\u20132013","volume":"67","author":"Zilberberg","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/518852","article-title":"Invasive aspergillosis in the intensive care unit","volume":"45","author":"Meersseman","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JCM.01767-09","article-title":"Aspergillus PCR: One step closer to standardization","volume":"48","author":"White","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: Systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"White","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmi.2015.09.009","article-title":"Prospective multicentre PCR-based aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis","volume":"22","author":"Springer","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol Infect."},{"key":"ref_17","unstructured":"Donnelly, J.P., Chen, S.C., Kauffman, C.A., Steinbach, W.J., Baddley, J.W., Verweij, P.E., Clancy, C.J., Wingard, J.R., Lockhart, S.R., and Groll, A.H. (2019). Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin. Infect. Dis."},{"key":"ref_18","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/JCM.01716-08","article-title":"Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia","volume":"47","author":"Meije","year":"2009","journal-title":"J. Clin. Microbiol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/bmt.2010.219","article-title":"Silent and prolonged aspergillus dnaemia in oncohematological patients receiving antifungal prophylaxis: A new phenomenon with clinical implications","volume":"46","author":"Meije","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/ciu833","article-title":"Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial","volume":"60","author":"Aguado","year":"2015","journal-title":"Clin. Infect. Dis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.12285","article-title":"Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies","volume":"161","author":"Rogers","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3389\/fmicb.2017.02040","article-title":"Circulating Aspergillus fumigatus DNA is quantitatively correlated to galactomannan in serum","volume":"8","author":"Alanio","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1128\/JCM.01655-16","article-title":"Application of mass spectrometry technology to early diagnosis of invasive fungal infections","volume":"54","author":"Mery","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/imj.12596","article-title":"Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014","volume":"44","author":"Morrissey","year":"2014","journal-title":"Intern. Med. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: A randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the european confederation of medical mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/mmy\/myy052","article-title":"Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?","volume":"57","author":"Jenks","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. Fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"NEJM"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2141.2001.02744.x","article-title":"Screening for Aspergillus spp. Using polymerase chain reaction of whole blood samples from patients with haematological malignancies","volume":"113","author":"Aigner","year":"2001","journal-title":"Br. J. Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JCM.42.9.4154-4157.2004","article-title":"Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples","volume":"42","author":"Gunsilius","year":"2004","journal-title":"J. Clin. Microbiol"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin. Infect. Dis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: Overview of the transplant-associated infection surveillance network (transnet) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis"},{"key":"ref_34","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: The seifem-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in aspergillus terreus and related species: An emerging problem or a rare phenomenon?","volume":"9","author":"Zoran","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijantimicag.2018.08.005","article-title":"Rare mould infections caused by mucorales, lomentospora prolificans and fusarium, in San Diego, CA: The role of antifungal combination therapy","volume":"52","author":"Jenks","year":"2018","journal-title":"Int. J. Antimicrob. Ag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","article-title":"Aspergillus species intrinsically resistant to antifungal agents","volume":"49","author":"Warris","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_38","first-page":"402","article-title":"Determining the analytical specificity of PCR-based assays for the diagnosis of ia: What is aspergillus?","volume":"55","author":"Morton","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/JCM.00411-17","article-title":"Analytical and clinical evaluation of the pathonostics aspergenius assay for detection of invasive aspergillosis and resistance to azole antifungal drugs directly from plasma samples","volume":"55","author":"White","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/1462-2920.14055","article-title":"Emergence of azole resistant Aspergillus fumigatus and one health: Time to implement environmental stewardship","volume":"20","author":"Chowdhary","year":"2018","journal-title":"Environ. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"Arendrup","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: A growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrmicro1179","article-title":"Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness","volume":"3","author":"Anderson","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fmicb.2018.00740","article-title":"Overview of commercially available PCR assays for the detection of Aspergillus spp. DNA in patient samples","volume":"9","author":"Rath","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1128\/JCM.03322-12","article-title":"Multicenter comparison of serum and whole-blood specimens for detection of aspergillus DNA in high-risk hematological patients","volume":"51","author":"Springer","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/JCM.02814-15","article-title":"Comparison of performance characteristics of aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations","volume":"54","author":"Springer","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/JCM.03233-15","article-title":"Comparison of nonculture blood-based tests for diagnosing invasive aspergillosis in an animal model","volume":"54","author":"White","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of aspergillus PCR for testing serum and plasma: A study by the European aspergillus PCR initiative","volume":"53","author":"White","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1128\/JCM.00906-15","article-title":"Analytical comparison of in vitro-spiked human serum and plasma for PCR-based detection of Aspergillus fumigatus DNA: A study by the european aspergillus PCR initiative","volume":"53","author":"Loeffler","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.2008.063321","article-title":"Don\u2019t throw your blood clots away: Use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosis","volume":"62","author":"McCulloch","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fimmu.2016.00404","article-title":"(1\u21923)-beta-D-glucan: A biomarker for microbial translocation in individuals with acute or early hiv infection?","volume":"7","author":"Hoenigl","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/mmy\/myv034","article-title":"Effects of host response and antifungal therapy on serum and bal levels of galactomannan and (1\u21923)-beta-D-glucan in experimental invasive pulmonary aspergillosis","volume":"53","author":"Petraitiene","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/myc.12869","article-title":"Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the fungal infections definitions in ICU patients (FUNDICU) project","volume":"62","author":"Bassetti","year":"2019","journal-title":"Mycoses"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: A randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: A tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.201407-1275OC","article-title":"Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases","volume":"190","author":"Prattes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: Analytical and clinical validity","volume":"50","author":"Theunissen","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and aspergillus specific nested polymerase chain reaction in a prospective pilot study","volume":"47","author":"Boch","year":"2018","journal-title":"J. Crit. Care"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/myc.12983","article-title":"Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis","volume":"62","author":"Boch","year":"2019","journal-title":"Mycoses"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Guinea, J., Padilla, C., Escribano, P., Munoz, P., Padilla, B., Gijon, P., and Bouza, E. (2013). Evaluation of mycassay aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061545"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/cir185","article-title":"Comparison of an aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients","volume":"52","author":"Luong","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/bmt.2010.38","article-title":"Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic sct","volume":"45","author":"Blennow","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40121-017-0183-9","article-title":"Challenges and solution of invasive aspergillosis in non-neutropenic patients: A review","volume":"7","author":"Bassetti","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet. Respirat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13054-015-0905-x","article-title":"Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients","volume":"19","author":"Eigl","year":"2015","journal-title":"Crit. Care"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: Results of the transplant-associated infection surveillance network (transnet)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1080\/13693780802227159","article-title":"Invasive aspergillosis in glucocorticoid-treated patients","volume":"47","author":"Lewis","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin. Microbiol. Infect.s"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/cncr.24559","article-title":"Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: Retrospective analysis of 1711 lung cancer cases","volume":"115","author":"Yan","year":"2009","journal-title":"Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"key":"ref_75","first-page":"2169","article-title":"Mycobiome in the lower respiratory tract\u2014A clinical perspective","volume":"7","author":"Krause","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2141.1999.01260.x","article-title":"Pulmonary aspergillus colonization in humans and its impact on management of critically ill patients","volume":"104","author":"Salzer","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.18869\/acadpub.cmm.1.3.45","article-title":"Aspergillus colonization in patients with chronic obstructive pulmonary disease","volume":"1","author":"Shahi","year":"2015","journal-title":"Curr. Med. Mycol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/mmy\/myy074","article-title":"Aspergillus colonization and antifungal immunity in cystic fibrosis patients","volume":"57","author":"Warris","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/jac\/dkw323","article-title":"PCR-based detection of Aspergillus fumigatus cyp51a mutations on bronchoalveolar lavage: A multicentre validation of the aspergenius assay(R) in 201 patients with haematological disease suspected for invasive aspergillosis","volume":"71","author":"Chong","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JCM.01032-17","article-title":"Molecular diagnosis of invasive aspergillosis and detection of azole resistance by a newly commercialized PCR kit","volume":"55","author":"Dannaoui","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_82","first-page":"75","article-title":"Detection of Pneumocystis jirovecii and aspergillus spp. DNA in bronchoalveolar lavage fluids by commercial real-time PCR assays: Comparison with conventional diagnostic tests","volume":"38","author":"Orsi","year":"2015","journal-title":"New Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/myc.12438","article-title":"The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients","volume":"59","author":"Oz","year":"2016","journal-title":"Mycoses"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/cid\/ciz215","article-title":"Fungal translocation: A driving force behind the occurrence of non-aids events?","volume":"70","author":"Hoenigl","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Weiner, L., Retuerto, M., Hager, C., El Kamari, V., Shan, L., Sattar, A., Kulkarni, M., Funderburg, N., Ghannoum, M., and Dirajlal-Fargo, S. (2019). Fungal translocation is associated with immune activation and systemic inflammation in treated HIV. AIDS Res. Hum. Retrov.","DOI":"10.1089\/aid.2018.0252"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Yang, A.M., Inamine, T., Hochrath, K., Chen, P., Wang, L., Llorente, C., Bluemel, S., Hartmann, P., Xu, J., and Koyama, Y. (2017). Intestinal fungi contribute to development of alcoholic liver disease. J. Clin. Invest.","DOI":"10.1172\/JCI90562"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cid\/ciz212","article-title":"Circulating (1\u21923)-beta-d-glucan is associated with immune activation during HIV infection","volume":"70","author":"Mehraj","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gianella, S., Letendre, S.L., Iudicello, J., Franklin, D., Gaufin, T., Zhang, Y., Porrachia, M., Vargas-Meneses, M., Ellis, R.J., and Finkelman, M. (2019). Plasma (1\u21923)-beta-D-glucan and supar levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: A charter analysis. J. Neurovirol.","DOI":"10.1007\/s13365-019-00775-6"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/JCM.01466-10","article-title":"Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens","volume":"48","author":"White","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/JCM.01365-14","article-title":"PCR in diagnosis of invasive aspergillosis: A meta-analysis of diagnostic performance","volume":"52","author":"Arvanitis","year":"2014","journal-title":"J. Clin. Microbiol"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Lenczuk, D., Zinke-Cerwenka, W., Greinix, H., Wolfler, A., Prattes, J., Zollner-Schwetz, I., Valentin, T., Lin, T.C., Meinitzer, A., and Hoenigl, M. (2018). Antifungal prophylaxis with posaconazole delayed-release tablet and oral suspension in a real-life setting: Plasma levels, efficacy, and tolerability. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.02655-17"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Witherden, E.A., Shoaie, S., Hall, R.A., and Moyes, D.L. (2017). The human mucosal mycobiome and fungal community interactions. J. Fungi, 3.","DOI":"10.3390\/jof3040056"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Suhr","year":"2017","journal-title":"Virulence"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hoenigl, M., Moser, C., Funderburg, N., Bosch, R., Kantor, A., Zhang, Y., Eugen-Olsen, J., Finkelman, M., Reiser, J., and Landay, A. (2018). Soluble urokinase plasminogen activator receptor (SUPAR) is predictive of non-aids events during antiretroviral therapy-mediated viral suppression. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciy966"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1439-0507.2008.01512.x","article-title":"Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases","volume":"51","author":"Cesaro","year":"2008","journal-title":"Mycoses"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0609.2010.01452.x","article-title":"Aspergillus PCR testing: Results from a prospective PCR study within the ambiload trial","volume":"85","author":"Hummel","year":"2010","journal-title":"Eur J. Haematol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","article-title":"Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, asp lfd, and aspergillus PCR in same day blood and bronchoalveolar lavage samples","volume":"77","author":"Heldt","year":"2018","journal-title":"J. Infect."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/myc.12322","article-title":"Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia","volume":"58","author":"Aslan","year":"2015","journal-title":"Mycoses"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JCM.01679-10","article-title":"Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients","volume":"49","author":"Springer","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/321887","article-title":"Detection of aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: Clinical results","volume":"33","author":"Buchheidt","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","first-page":"81","article-title":"Early diagnosis of invasive aspergillosis in neutropenic patients. Comparison between serum galactomannan and polymerase chain reaction","volume":"4","author":"Ribeiro","year":"2010","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients","volume":"6","author":"Badiee","year":"2012","journal-title":"J. Infect. Dev. Ctries"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/1\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:30:33Z","timestamp":1760362233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/6\/1\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["jof6010018"],"URL":"https:\/\/doi.org\/10.3390\/jof6010018","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]}}}